Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Hamilton Thorne Ltd (HTL.TO)

Hamilton Thorne Ltd (HTL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Hamilton Thorne Ltd 100 Cummings Center Suite 465E Beverly MA 01915 USA

https://www.hamiltonthorne.ltd P: 978-921-2050 F: 978-921-0250

Description:

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Key Statistics

Overview:

Market Capitalization, $K 213,709
Shares Outstanding, K 153,748
Annual Sales, $ 67,225 K
Annual Net Income, $ -607 K
Last Quarter Sales, $ 19,393 K
Last Quarter Net Income, $ -936 K
60-Month Beta -0.61
% of Institutional Shareholders 7.73%

Growth:

1-Year Return -10.83%
3-Year Return -25.93%
5-Year Return 29.63%
5-Year Revenue Growth 18.14%

Per-Share Information:

Next Earnings Date 05/14/24
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year -660.19%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 11/06/09

HTL.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 50.76
Price/Earnings to Growth N/A
Return-on-Equity % -2.67%
Return-on-Assets % -1.67%
Profit Margin % -0.90%
Debt/Equity 0.34
Price/Sales 2.20
Price/Book 2.48
Book Value/Share 0.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar